Device Trial Radar · NCT03361995
STEMI Cool Pilot Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI (Phase A)
Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Feb 20, 2020
Primary completion
May 12, 2022
Study completion May 12, 2022
Sponsor
- Lead sponsor
- ZOLL Circulation, Inc., USANot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 5, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multicenter, Prospective, Randomized-Controlled Trial to Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention In Patients with Acute Myocardial Infarction. The Phase A portion of the trial will include 80 enrollments from up to 15 sites.
Conditions
- Acute Myocardial Infarction
Interventions
Cooling Procedure using the ZOLL Thermogard XP3 IVTM SystemDevice
Cooling Procedure with ZOLL Thermogard XP3 IVTM System before and after Percutaneous Coronary Intervention (PCI)
PCIDevice
Standard of Care for PCI
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase A Safety Endpoint: Incidence of MACE at 30 days.Time frame: Through study completion, approximately 1 year
- Phase A Device Performance Endpoint: Proportion of cooled patients who reach ≤34° at PCI.Time frame: Through study completion, approximately 1 year
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.